中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Author Name	Affiliation	E-mail
ZHAO Rui-hua	1. Grade 2010, Ph.D, Shandong University of Traditional Chinese Medicine, Jinan (250355), China 2. Department of Genecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China	rhzh801@sohu.com
LIU Yong	Department of Genecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China
TAN Yong	Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing (210029), China
HAO Zeng-ping	Beijing Friendship Hospital, Capital Medical University, Beijing (100050), China
MENG Qing-wei	Beijing Hospital of the Ministry of Health, Beijing (100730), China
WANG Rui	Beijing Tiantan Hospital, Capital Medical University, Beijing (100050), China
LONG Di	Fuxing Hospital, Capital Medical University, Beijing (100038), China
DING Yong-fen	Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing (100102), China
SONG Dian-rong	The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin (300150), China
XU Cai	Department of Genecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China
REN Zhi-zhen	Department of Genecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China
YANG Yan-huan	Department of Genecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China
WANG Ai-ming	PLA Navy General Hospital, Beijing (100048), China

Hits: 1566

Download times: 1237

Abstract:

Objective: To investigate the effect of Chinese medicine (CM) and Western medicine (WM) on quality of life (QOL) after conservative surgery for endometriosis. Methods: A total of 320 patients with endometriosis were randomized into two groups by using random block design, CM group (160 cases, activating blood circulation and removing blood stasis treatment based on syndrome differentiation) and WM group (160 cases, gonadotropin-releasing hormone agonist or gestrinone treatment) after conservative surgery. Treatment was given for 3–6 months (according to the revised American Fertility Society scoring system stage), and the World Health Organization QOL-BREF (WHOQOL-BREF) was applied to patients before and after treatment to assess QOL. Results: There were 136 cases in the CM group and 141 cases in the WM group completing therapy. In the CM group, the use of the WHOQOL-BREF showed that the physical, psychological and environmental scores post-treatment were significantly higher than those at pre-treatment (P<0.05), and for 12 items (pain and discomfort, energy and fatigue, sleep and rest, mobility, activities of daily living, work capacity, negative feelings, health and social care: accessibility and quality, participation in and opportunities for recreation/leisure activities, appetite, QOL score, overall health status and QOL), the difference in scores was significant (P<0.05). In the WM group, 4 items (pain and discomfort, opportunities for acquiring new information and skills, QOL score, overall health status and QOL) had significantly different scores post-treatment compared with those at pre-treatment (P<0.05). Before treatment, the QOL in the two groups of patients showed no significant difference (P>0.05). After treatment, the scores for physical health in the CM group were significantly higher than those of the WM group (P<0.05) and the scores of 4 items (mobility, activities of daily living, sexual activity, QOL score) in the CM group were significantly higher than those in the WM group (P<0.05). Conclusions: CM and WM treatment could improve the QOL of patients with endometriosis after conservative surgery. CM treatment is more effective than WM.